Stocks Health care ADGM
NASDAQ · Health careAdagio Medical Holdings, Inc. (ADGM)
Adagio Medical Holdings, Inc. brought in $0 of revenue over the twelve months to June 30, 2026. It posted a net loss of $27.1M. In fiscal 2025 capital spending exceeded operating cash flow by $19.4M. At June 30, 2026 it held $7.7M in cash against $24.8M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 11, 2026.
Key facts about Adagio Medical Holdings, Inc.
- Net worth
- Adagio Medical Holdings, Inc. has a market value (market cap) of $41.5M at the latest share price, and shareholders' equity of -$415K on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $0 (-100.0% year on year), with a net loss of $25.1M. Over the 12 months to June 30, 2026: revenue $0, net loss $27.1M.
- Cash flow
- In fiscal 2025 operations used $19M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 11, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Adagio Medical Holdings, Inc.'s next report was expected around November 10, 2026 and is not on file with the SEC yet.
What Adagio Medical Holdings, Inc. does
Adagio Medical Holdings, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker ADGM.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $0 | -$25.1M | -$1.51 | -$19.4M |
| 2024 | $300K | -$36.6M | -$48.16 | -$26M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Adagio Medical Holdings, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 1, 2026
- October 1, 2026Preliminary proxy statement PRE 14A
- September 23, 2026Restructuring or layoffs8-KAdagio Medical announced a reduction of 25 employees and started a process to explore strategic alternatives.
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 14, 2026
- August 13, 2026
- August 11, 2026
- August 11, 2026
- July 28, 2026Passive stake changed SCHEDULE 13G/A
- July 13, 2026
Insider trades
What the people running Adagio Medical Holdings, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| December 16, 2025 | Kaster DeborahChief Financial Officer | Bought | 15,000 | $18K |
| December 12, 2025 | Usen ToddChief Executive Officer, Director | Bought | 207,315 | $226K |
Who owns ADGM
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Perceptive Advisors LLC13G, passive with 3 related filers | 55.4% | May 15, 2026 |
| Alyeska Investment Group, L.P.13G, passive with 2 related filers | 9.9% | February 17, 2026 |
| RA Capital Management, L.P.13G, passive with 3 related filers | 7.2% | August 26, 2025 |
| Adage Capital Management, L.P.13G, passive with 2 related filers | 5.67% | May 13, 2026 |
| ADAR1 Capital Management, LLC13G, passive with 1 related filers | 5.4% | August 14, 2026 |
Largest institutional holders
Insiders
2 insiders reported holding 222,315 shares in total, about $415.7K at the last price.
| Holder | Shares |
|---|---|
| Usen ToddChief Executive Officer, Director | 207,315 |
| Kaster DeborahChief Financial Officer | 15,000 |
Questions about ADGM
What does Adagio Medical Holdings, Inc. do?
Adagio Medical Holdings, Inc. is a company in the Health care sector, listed on NASDAQ as ADGM. Its shares trade on NASDAQ under the ticker ADGM.
What is Adagio Medical Holdings, Inc.'s net worth?
Adagio Medical Holdings, Inc. has a market value (market cap) of $41.5M at the latest share price, and shareholders' equity of -$415K on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Adagio Medical Holdings, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $27.1M.
How much revenue does Adagio Medical Holdings, Inc. make?
Over the twelve months to June 30, 2026 Adagio Medical Holdings, Inc. reported revenue of $0.
When did Adagio Medical Holdings, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 11, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the unregistered share sale from October 1, 2026.
When is Adagio Medical Holdings, Inc.'s next earnings report?
Adagio Medical Holdings, Inc.'s next report was expected around November 10, 2026 and is not on file with the SEC yet.
Similar companies
Compare ADGM with
Follow ADGM
Get an email when Adagio Medical Holdings, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Adagio Medical Holdings, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.